Antiplatelet therapy with P2Con12 receptor inhibitors (clopidogrel, prasugrel, ticagrelor, cangrelor) is a cornerstone of medical therapy after percutaneous coronary interventions. obtainable tests, a analysis of either HTPR or LTPR predicated on 1 method could be unconfirmed by using a different technique. Relating to both American and Western groups of specialists you can find three suggested… Continue reading Antiplatelet therapy with P2Con12 receptor inhibitors (clopidogrel, prasugrel, ticagrelor, cangrelor) is a cornerstone of medical therapy after percutaneous coronary interventions